mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.06 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.52 |
0.07 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |